News

Danish drugmaker Novo Nordisk said several hundred counterfeit units of its diabetes drug Ozempic were being distributed in ...
Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic were being ...
Obesity causes various chronic diseases and conditions, including type 2 diabetes ... supply. Novo Nordisk hasn't been able to add manufacturing capacity fast enough. The U.S. Food and Drug ...
As the ultra-processed food (UPF) conversation continues ... The project was backed by the Novo Nordisk Foundation, the controlling shareholder of the big pharma business famous for making diabetes ...
Novo Nordisk ... with Novo Nordisk’s flagship drug semaglutide, marketed as Ozempic in type 2 diabetes and Wegovy in obesity, led to greater weight loss and reductions in food intake and fat ...
Novo Nordisk Warns Consumers About Counterfeit Versions of Ozempic in US (Reuters) - Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit units of its diabetes drug Ozempic ...
The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to treat Type 2 diabetes, have been found in the United States. Novo Nordisk ...
Earlier in 2025, the U.S. Food and Drug Administration (FDA ... Richard Pratley, MD is a paid Novo Nordisk, Inc. spokesperson. Only Novo Nordisk manufactures FDA-approved semaglutide medicines, ...
Copenhagen, DENMARK — Obesity drug giant Novo Nordisk ... Novo's Wegovy and diabetes drug Ozempic, both known chemically as semaglutide, under a drug shortage ruling by the Food and Drug ...